241 related articles for article (PubMed ID: 19738604)
1. Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.
Huang JH; Zhang SN; Choi KJ; Choi IK; Kim JH; Lee MG; Lee M; Kim H; Yun CO
Mol Ther; 2010 Feb; 18(2):264-74. PubMed ID: 19738604
[TBL] [Abstract][Full Text] [Related]
2. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
[TBL] [Abstract][Full Text] [Related]
3. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.
Zhang SN; Choi IK; Huang JH; Yoo JY; Choi KJ; Yun CO
Mol Ther; 2011 Aug; 19(8):1558-68. PubMed ID: 21468000
[TBL] [Abstract][Full Text] [Related]
4. Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.
Weng X; Kuang Y; Liu X; Chen Z; Zhu H; Chen H; Jiang B; Shen H
Braz J Med Biol Res; 2011 Mar; 44(3):186-92. PubMed ID: 21243315
[TBL] [Abstract][Full Text] [Related]
5. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
Oh E; Choi IK; Hong J; Yun CO
Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
[TBL] [Abstract][Full Text] [Related]
7. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
[TBL] [Abstract][Full Text] [Related]
8. Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.
Youlin K; Li Z; Xin G; Mingchao X; Xiuheng L; Xiaodong W
Hum Vaccin Immunother; 2013 Apr; 9(4):766-72. PubMed ID: 23295983
[TBL] [Abstract][Full Text] [Related]
9. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
[TBL] [Abstract][Full Text] [Related]
10. The change of immunoactivity of dendritic cells induced by mouse 4-1BBL recombinant adenovirus.
Youlin K; Xiaodong W; Xiuheng L; Zhiyuan C; Hengcheng Z; Hui C; Botao J
Yonsei Med J; 2010 Jul; 51(4):594-8. PubMed ID: 20499429
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
[TBL] [Abstract][Full Text] [Related]
12. Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.
Youlin K; Jian K; Siming L; Li Z; Weiyang H; Chaodong L; Xin G
Immunotherapy; 2015; 7(1):13-20. PubMed ID: 25572476
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
Ahn HM; Hong J; Yun CO
Oncotarget; 2016 Dec; 7(51):84965-84980. PubMed ID: 27821803
[TBL] [Abstract][Full Text] [Related]
14. Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L.
Lu SC; Hansen MJ; Hemsath JR; Parrett BJ; Zell BN; Barry MA
Hum Gene Ther; 2022 Mar; 33(5-6):250-261. PubMed ID: 34731019
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.
Yang Z; Zhang Q; Xu K; Shan J; Shen J; Liu L; Xu Y; Xia F; Bie P; Zhang X; Cui Y; Bian XW; Qian C
PLoS One; 2012; 7(9):e44802. PubMed ID: 23028626
[TBL] [Abstract][Full Text] [Related]
16. Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.
Wang R; Freywald A; Chen Y; Xu J; Tan X; Xiang J
Cell Mol Immunol; 2015 Jul; 12(4):456-65. PubMed ID: 25195511
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
18. Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8
Chen D; Huang L; Zhou H; Zhang Y
Front Immunol; 2021; 12():615089. PubMed ID: 33717103
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
[TBL] [Abstract][Full Text] [Related]
20. Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.
Li G; Wu X; Zhang F; Li X; Sun B; Yu Y; Yin A; Deng L; Yin J; Wang X
J Cancer Res Clin Oncol; 2011 Apr; 137(4):695-703. PubMed ID: 20563597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
